Bioruptor Plus Pico Sonication Device
- Response deadline
- Jul 24, 2026 Closed
- Date posted
- Jul 9, 2026
- Source
- Open notice
Description
The Bioruptor® Pico sonication device is uniquely positioned to meet the Government’s needs. This all-in-one shearing system is optimized for processing micro-volumes ranging from 5 µl to 2 ml, accommodating a wide array of sample types, including deoxyribonucleic acid, ribonucleic acid, and chromatin. Its ability to simultaneously sonicate 6 to 12 samples ensures high-throughput capabilities, which is crucial for our large-scale studies. The device's advanced timing control and integrated cooling system provide precise temperature regulation, preserving sample integrity and ensuring reproducible fragmentation profiles. Furthermore, the Bioruptor® Pico's compatibility with various sample types, including formalin-fixed paraffin-embedded tissues and plant samples, enhances its versatility and applicability across different research projects. Its user-friendly design and robust performance have been validated through numerous peer-reviewed publications, underscoring its reliability in generating high-quality data. In summary, the Bioruptor® Pico sonication device aligns with the laboratory's needs for efficient, reproducible, and scalable sample preparation. Investing in this technology will not only streamline workflows but also enhance the quality and consistency of our research outcomes.
Documents (1)
- DownloadNHGRI-09201 Notice of Intent.docx.docx20 KB
Contacts
Similar contracts
- Notice of Intent to Award Sole Source – ScholarOne Licenses RenewalGeorgiaDue Aug 31, 2026
- Notice of Intent to Award Sole Source – ArcGIS Licenses RenewalGeorgiaDue Aug 31, 2026
- Intent to Sole Source to Thermo Fisher for on-site preventative maintenance and full-service ISO 9001 calibration on 21 IncubatorsWest VirginiaDue Aug 31, 2026
- Globus Licenses Renewal - NIH/NEIMarylandDue Aug 14, 2026
- Notice of Sole Source: GastroPlus PBPK and PBBM modeling platform subscriptionMarylandDue Aug 14, 2026
- Antioxidant Therapy for Smith-Lemli-Opitz SyndroneMarylandDue Aug 18, 2026